Trial intelligence / Profile preview

Magnesium use to reduce anesthetic drug requirement during fiberoptic bronchoscopy

IRCT20250923067343N5Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Apr 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of magnesium, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Primary anesthetic drug requirement. Started Apr 2026; status: completed.

02

Drugs

magnesium

Beyond the preview

Go deeper on IRCT20250923067343N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250923067343N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call